Ignite Creation Date:
2024-05-06 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05043129
Status:
UNKNOWN
Last Update Posted:
2021-09-17
First Post:
2021-09-10
Brief Title:
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Organization:
The Second Affiliated Hospital of Chongqing Medical University
Study Overview
Official Title:
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
On 11 February 2020 the International Committee for the Classification of Viruses named the disease caused by SAＲS-CoV-2 infection in humans as the new coronavirus pneumonia coronavirus disease 2019 COVID-19 People infected with human immunodeficiency virus HIV are affected by their underlying diseases and are listed by the World Health Organization WHO as a high-risk population of SARS-CoV-2 infectionTo evaluate the safety and effectiveness of COVID-19 vaccine in those patients with human immunodeficiency virus infection and to guide the COVID-19 vaccination more scientifically reasonably and effectively this study was carried out
Detailed Description:
People infected with human immunodeficiency virus HIV affected by their underlying diseases are listed by the World Health Organization WHO as a high-risk population for SARS-CoV-2 infection More attention should be paid to personal protection and disease prevention Vaccination of COVID-19 can effectively prevent COVID-19 virus infection and delay or prevent patients from developing into critical illness and reduce mortality The safety and effectiveness of COVID-19 vaccine in this population were evaluated in order to play a scientific and theoretical supporting role in guiding COVID-19 vaccination more scientifically reasonably and effectively The samples of this study were collected and tested in the second affiliated Hospital of Chongqing Medical University Patients with contraindications for vaccination will be excluded The detected indexes included blood routine test CD4 HIV virus load COVID-19 antibody titer antibody duration and other indexes of healthy people control group and HIV infenction people after vaccination 1 3 6 months after vaccination The adverse reactions related to the vaccine were recorded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None